berberine vs semaglutide **Ozempic** in 2026 Liraglutide vs Semaglutide: Comparing Weight

Source: Indian Journal of Gastroenterology

As we approach launch, Zach is looking for a CTO / technical co-founder to help scale the platform

United by a shared mission to enhance obesity care, MYOS focuses on advancing clinical practice, raising awareness, and sharing expertise to improve the lives of people affected by obesity.

Semaglutide is an FDA-approved GLP-1 (glucagon-like peptide-1) receptor agonist that helps to control blood glucose levels and assists in long-term weight

Smaller portions that feel manageable

As of early 2026, several potent single, dual, and triple incretin receptor agonists are in Phase 2/3 trials for MASH including : Survodutide : A dual glucagon (GCGR)/GLP-1 receptor agonist that has shown significant MASH resolution in Phase 2 trials